Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Clinical and Experimental Rheumatology|February 18, 2016
Increased visfatin levels are associated with higher disease activity in anti-Jo-1-positive myositis patientsHana Hulejová, Olga Kryštůfková, Heřman Mann, et al.
Annals of the Rheumatic Diseases|August 29, 2014
A tailored approach to reduce dose of anti-TNF drugs may be equally effective, but substantially less costly than standard dosing in patients with ankylosing spondylitis over 1 year: a propensity score-matched cohort studyJakub Závada, Michal Uher, Katarína Sisol, et al.
Rheumatology and Therapy|May 23, 2023
Effect of an 8-Week Tailored Physiotherapy Program on Sexual Health in Women with Scleroderma and Myositis: A Controlled Pilot StudyBarbora Heřmánková, Maja Špiritović, Sabína Oreská, et al.
Scientific Reports|June 2, 2021
Clusterin serum levels are elevated in patients with early rheumatoid arthritis and predict disease activity and treatment responseTereza Kropáčková, Heřman Mann, Olga Růžičková, et al.
Scientific Reports|October 6, 2025
Machine learning-assisted screening of clinical features for predicting difficult-to-treat rheumatoid arthritisJiří Baloun, Lucie Andrés Cerezo, Tereza Kropáčková, et al.
Scientific Reports|April 18, 2026
Cellular miRNA-31 and miRNA-125b as predictors of remission and major disease improvement in patients with early rheumatoid arthritisVeronika Horváthová, Lucia Vernerová, Klára Prajzlerová, et al.
Plos One|July 29, 2014
Decreased circulating visfatin is associated with improved disease activity in early rheumatoid arthritis: data from the PERAC cohortOndřej Sglunda, Heřman Mann, Hana Hulejová, et al.
Rheumatology and Therapy|June 23, 2019
Efficacy and Safety of Subcutaneous Secukinumab 150 mg with or Without Loading Regimen in Psoriatic Arthritis: Results from the FUTURE 4 StudyAlan J Kivitz, Peter Nash, Hasan Tahir, et al.
Frontiers in Immunology|July 30, 2026
Case Report: Immune checkpoint inhibitor-induced IgG4-related disease mimicking renal metastatic progression: successful steroid-sparing management with rituximabMayara Elisa Bonatto, Jan Dvořák, Marek Kollár, et al.
Rheumatology International|April 27, 2019
Serum visfatin levels in patients with axial spondyloarthritis and their relationship to disease activity and spinal radiographic damage: a cross-sectional studyHana Hulejová, Tereza Kropáčková, Kristýna Bubová, et al.
Pageof 4